Trial intelligence / Profile preview

Levetiracetam adjunctive treatment in Japanese pediatric GTC seizures

NCT01292837Phase 3Completed

Sponsor
UCB
Start
Feb 2011
Primary completion
Jun 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of levetiracetam in generalized tonic-clonic seizure (GTCS), sponsored by UCB. Started Feb 2011; status: completed.

02

Drugs

levetiracetam
03

Conditions

generalized tonic-clonic seizure (GTCS)

Beyond the preview

Go deeper on NCT01292837.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01292837.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call